Research Options: Select below IPO Calendar	Week of Expected Pricing Pending Company Name POSEIDA THERAPEUTICS, INC Proposed Ticker PSTX CUSIP N/A Business Description A clinical-stage biopharmaceutical company focused on leveraging our proprietary next-generation, non-viral gene engineering technologies to create life-saving therapeutics for patients with high unmet medical need Lead Underwriter Citigroup Global Markets Inc , Credit Suisse Securities (USA) LLC , Wells Fargo Securities, LLC Co-Managers N/A Initial Shares N/A Revised Initial Shares N/A Initial Price N/A Revised Price N/A Final Price N/A Final Ticker N/A
	© 2024 ICE Data Services. All rights reserved.